Language Select


Recent News
Oct 27, 2016

Varian Medical Systems (NYSE: VAR) today announced Grupo Oncoclínicas, the largest private cancer center network in Latin America, acquired thirteen medical linear accelerators, five TrueBeam™...

Oct 26, 2016

Varian Medical Systems (NYSE: VAR) and McKesson Specialty Health today announced a strategic agreement for the deployment and servicing of Varian advanced radiotherapy equipment and software over...

Oct 26, 2016

Varian Medical Systems (NYSE: VAR) today announced that Elisha W. Finney has informed the company of her intention to retire as executive vice president and chief financial officer. Finney, 55,...

More news >

Recent Blog Posts
Oct 19, 2016Spot ON
In this Q&A, Dr. Perentesis shares his thoughts on some of the benefits of proton therapy research including reducing side effects and secondary cancers, as well as improving long-term outcomes.
Read more
Oct 5, 2016Spot ON
The Center for Proton Therapy at the Paul Scherrer Institute focuses research on the optimization of treatment delivery and development of innovative treatment concepts. In this Q&A, Dr. Weber offers his insight and experience in proton therapy.
Read more
Sep 21, 2016Spot ON
Highlighted at the Varian Medial Systems' booth #5063 at ASTRO will be the ProBeam® Compact Single-Room Proton Therapy System that offers end-to-end integration, enabling adaptive therapy for better patient care.
Read more
Corporate Communications Contacts
Spencer Sias
Vice President, Corporate Communications and Investor Relations
Mark Plungy
Director, Public Relations
Neil Madle
Director, Corporate Communications/Investor Relations, Europe
+44 (0)7786 526 068
  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.